Study on the risk signal mining related to denosumab based on the US Food and Drug Administration Adverse Event Reporting System

Peng Jing, Jiang Kaijie, Ren Xiaolei, Wu Mingli, Zhao Yanyan, Wang Meixia, Meng Luhua, Liu Zhen, Wang L

PDF(386 KB)
PDF(386 KB)
Adverse Drug Reactions Journal ›› 2022, Vol. 24 ›› Issue (2) : 67-73. DOI: 10.3760/cma.j.cn114015-20210813-00897

Study on the risk signal mining related to denosumab based on the US Food and Drug Administration Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 24(2): 67-73 https://doi.org/10.3760/cma.j.cn114015-20210813-00897

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(386 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉